Cat. No. ARC1042
KMM-1 is a human myeloma cell line, established from the subcutaneous myeloma of a 62-year-old male patient. KMM-1 cells show the characteristics of plasma cell at the later stage B-cell differentiation. They can express cytoplasmic lambda antigen and secret lambda chains into the culture medium. Moreover, the KMM-1 cells can react with the monoclonal antibodies of PCA-1 and CD38. This cell line is ENBA negative and non-turmogenic. <br> <br>Synonyms: KMM1 <br> <br> <span style="font-size:14px">Namba, M., Ohtsuki, T., Mori, M., Togawa, A., Wada, H., Sugihara, T., Yawata, Y., & Kimoto, T. (1989). Establishment of five human myeloma cell lines. <em>In vitro cellular & developmental biology : journal of the Tissue Culture Association</em>, 25(8), 723–729. https://doi.org/10.1007/BF02623725</span>
| Sex of Donor | Male |
| Age | 62 years |
| Derived From Site | In situ, Subcutaneous myeloma (Igλ) |
| Morphology | Lymphocyte-like |
| Growth Mode | Suspension |
| Temperature | 37°C |
| Atmosphere | 5% CO₂ |
| Sterility testing | The bacterial, yeast, and fungi are not detected in these cells by daily monitor. |
| Mycoplasma testing | Negative for mycoplasma through PCR analysis |
Intended Use: This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer: Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use.
This product is provided "AS IS". For Research Use Only. Not for human or animal therapeutic use.